Ptc Therapeutics (PTCT) Exchange Rate Effect (2015 - 2026)
Ptc Therapeutics (PTCT) recorded quarterly Exchange Rate Effect of -$1.5 million in Q1 2026, down 115.56% quarter-over-quarter from $9.8 million in Q4 2025, and down 128.26% on a YoY basis from $5.4 million in Q1 2025.
Ptc Therapeutics (PTCT) Exchange Rate Effect (2015 - 2026) Analysis & Trends
Ptc Therapeutics' Exchange Rate Effect history runs 12 years deep, the most recent figure standing at -$1.5 million for Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 128.26% year-over-year to -$1.5 million; the TTM figure through Mar 2026 stood at $15.8 million (up 16526.32% YoY), while the FY2025 annual figure was $22.7 million, up 409.93% from the prior year.
- Exchange Rate Effect was -$1.5 million for Q1 2026 at Ptc Therapeutics, down from $9.8 million in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $13.6 million in Q2 2025 to a low of -$12.1 million in Q3 2022.
- Historically, Exchange Rate Effect has averaged $835411.8 across 5 years, with a median of $1.7 million in 2022.
- Biggest YoY gain for Exchange Rate Effect was 508.85% in 2023; the steepest drop was 581.73% in 2023.
- A 5-year view of Exchange Rate Effect shows it stood at $6.0 million in 2022, then plunged by 48.59% to $3.1 million in 2023, then sank by 379.58% to -$8.7 million in 2024, then jumped by 213.2% to $9.8 million in 2025, then plunged by 115.56% to -$1.5 million in 2026.
- The last three Exchange Rate Effect figures came in at -$1.5 million (Q1 2026), $9.8 million (Q4 2025), and -$6.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Ptc Therapeutics | 6.51 Bn | 4.61 Bn | 244.52 Mn | -1.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.52 Mn |
| Mar 31, 2026 | -1.52 Mn |
| Dec 31, 2025 | 9.80 Mn |
| Dec 31, 2025 | 9.80 Mn |
| Sep 30, 2025 | -6.06 Mn |
| Sep 30, 2025 | -6.06 Mn |
| Jun 30, 2025 | 13.59 Mn |
| Jun 30, 2025 | 13.59 Mn |
| Mar 31, 2025 | 5.39 Mn |
| Mar 31, 2025 | 5.39 Mn |
| Dec 31, 2024 | -8.65 Mn |
| Dec 31, 2024 | -8.65 Mn |
| Sep 30, 2024 | 8.54 Mn |
| Sep 30, 2024 | 8.54 Mn |
| Jun 30, 2024 | -5.19 Mn |
| Jun 30, 2024 | -5.19 Mn |
| Mar 31, 2024 | -2.03 Mn |
| Mar 31, 2024 | -2.03 Mn |
| Dec 31, 2023 | 3.10 Mn |
| Dec 31, 2023 | 3.10 Mn |